US Bancorp DE Cuts Stake in Agilent Technologies, Inc. $A

US Bancorp DE reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 2.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 58,821 shares of the medical research company’s stock after selling 1,520 shares during the period. US Bancorp DE’s holdings in Agilent Technologies were worth $6,942,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Allegiance Financial Group Advisory Services LLC purchased a new position in shares of Agilent Technologies during the 2nd quarter worth about $230,000. Vontobel Holding Ltd. lifted its holdings in shares of Agilent Technologies by 12.7% during the 2nd quarter. Vontobel Holding Ltd. now owns 21,916 shares of the medical research company’s stock worth $2,586,000 after acquiring an additional 2,472 shares during the period. Maryland State Retirement & Pension System lifted its holdings in shares of Agilent Technologies by 3.2% during the 2nd quarter. Maryland State Retirement & Pension System now owns 13,849 shares of the medical research company’s stock worth $1,634,000 after acquiring an additional 425 shares during the period. Sitrin Capital Management LLC lifted its holdings in shares of Agilent Technologies by 34.3% during the 2nd quarter. Sitrin Capital Management LLC now owns 47,356 shares of the medical research company’s stock worth $5,588,000 after acquiring an additional 12,097 shares during the period. Finally, Dohj LLC lifted its holdings in shares of Agilent Technologies by 12.6% during the 2nd quarter. Dohj LLC now owns 6,581 shares of the medical research company’s stock worth $777,000 after acquiring an additional 738 shares during the period.

Agilent Technologies Stock Down 2.5%

Shares of NYSE:A opened at $136.62 on Monday. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The company has a 50 day moving average of $125.04 and a two-hundred day moving average of $117.02. The company has a market capitalization of $38.73 billion, a price-to-earnings ratio of 32.07, a price-to-earnings-growth ratio of 4.46 and a beta of 1.26.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the company earned $1.32 earnings per share. Agilent Technologies’s revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be given a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. UBS Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and increased their target price for the stock from $130.00 to $170.00 in a research report on Wednesday, October 8th. JPMorgan Chase & Co. increased their target price on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday. Wells Fargo & Company increased their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 target price for the company. Finally, Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average target price of $148.69.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.